img

Global Dendritic Cell Therapy Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dendritic Cell Therapy Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Dendritic cells are antigen-presenting cells found in lymphoid organs, their primary role is to activate T cells and display antigens. Antigen display aids in pathogen and microbe recognition by T-cells, allowing for their eradication and identification from the body. These cells aid in the capture and processing of tumor antigens, resulting in the activation of lymphocyte co-stimulatory molecules and the production of cytokines to trigger the immune response.
Dendritic Cell Therapy Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dendritic Cell Therapy Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Lung Cancer and Prostatic Cancer are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dendritic Cell Therapy Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Argos Therapeutics
JW Creagene
DanDrit Biotech
DCPrime
Elios Therapeutics Inc
ImmunoCellular Therapeutics Ltd
Immunicum AB
Tella Inc
Northwest Biotherapeutics Inc
Glaxo plc
Segment by Type
Intravenous Injection
Subcutaneous Injection
Intratumoral Injection

Segment by Application


Lung Cancer
Prostatic Cancer
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dendritic Cell Therapy Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dendritic Cell Therapy Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dendritic Cell Therapy Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dendritic Cell Therapy Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dendritic Cell Therapy Vaccine introduction, etc. Dendritic Cell Therapy Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dendritic Cell Therapy Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Dendritic Cell Therapy Vaccine Market Overview
1.1 Dendritic Cell Therapy Vaccine Product Overview
1.2 Dendritic Cell Therapy Vaccine Market Segment by Type
1.2.1 Intravenous Injection
1.2.2 Subcutaneous Injection
1.2.3 Intratumoral Injection
1.3 Global Dendritic Cell Therapy Vaccine Market Size by Type
1.3.1 Global Dendritic Cell Therapy Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Dendritic Cell Therapy Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Dendritic Cell Therapy Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dendritic Cell Therapy Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Dendritic Cell Therapy Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Dendritic Cell Therapy Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Dendritic Cell Therapy Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Dendritic Cell Therapy Vaccine Sales Breakdown by Type (2018-2024)
2 Global Dendritic Cell Therapy Vaccine Market Competition by Company
2.1 Global Top Players by Dendritic Cell Therapy Vaccine Sales (2018-2024)
2.2 Global Top Players by Dendritic Cell Therapy Vaccine Revenue (2018-2024)
2.3 Global Top Players by Dendritic Cell Therapy Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Dendritic Cell Therapy Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dendritic Cell Therapy Vaccine Market Competitive Situation and Trends
2.5.1 Dendritic Cell Therapy Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Dendritic Cell Therapy Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dendritic Cell Therapy Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Dendritic Cell Therapy Vaccine Market
2.8 Key Manufacturers Dendritic Cell Therapy Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dendritic Cell Therapy Vaccine Status and Outlook by Region
3.1 Global Dendritic Cell Therapy Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dendritic Cell Therapy Vaccine Historic Market Size by Region
3.2.1 Global Dendritic Cell Therapy Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Dendritic Cell Therapy Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Dendritic Cell Therapy Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Dendritic Cell Therapy Vaccine Forecasted Market Size by Region
3.3.1 Global Dendritic Cell Therapy Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Dendritic Cell Therapy Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Dendritic Cell Therapy Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dendritic Cell Therapy Vaccine by Application
4.1 Dendritic Cell Therapy Vaccine Market Segment by Application
4.1.1 Lung Cancer
4.1.2 Prostatic Cancer
4.1.3 Other
4.2 Global Dendritic Cell Therapy Vaccine Market Size by Application
4.2.1 Global Dendritic Cell Therapy Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Dendritic Cell Therapy Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Dendritic Cell Therapy Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dendritic Cell Therapy Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Dendritic Cell Therapy Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Dendritic Cell Therapy Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Dendritic Cell Therapy Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Dendritic Cell Therapy Vaccine Sales Breakdown by Application (2018-2024)
5 North America Dendritic Cell Therapy Vaccine by Country
5.1 North America Dendritic Cell Therapy Vaccine Historic Market Size by Country
5.1.1 North America Dendritic Cell Therapy Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dendritic Cell Therapy Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Dendritic Cell Therapy Vaccine Sales in Value by Country (2018-2024)
5.2 North America Dendritic Cell Therapy Vaccine Forecasted Market Size by Country
5.2.1 North America Dendritic Cell Therapy Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Dendritic Cell Therapy Vaccine Sales in Value by Country (2024-2029)
6 Europe Dendritic Cell Therapy Vaccine by Country
6.1 Europe Dendritic Cell Therapy Vaccine Historic Market Size by Country
6.1.1 Europe Dendritic Cell Therapy Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dendritic Cell Therapy Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Dendritic Cell Therapy Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Dendritic Cell Therapy Vaccine Forecasted Market Size by Country
6.2.1 Europe Dendritic Cell Therapy Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Dendritic Cell Therapy Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Dendritic Cell Therapy Vaccine by Region
7.1 Asia-Pacific Dendritic Cell Therapy Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Dendritic Cell Therapy Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dendritic Cell Therapy Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Dendritic Cell Therapy Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Dendritic Cell Therapy Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Dendritic Cell Therapy Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dendritic Cell Therapy Vaccine Sales in Value by Region (2024-2029)
8 Latin America Dendritic Cell Therapy Vaccine by Country
8.1 Latin America Dendritic Cell Therapy Vaccine Historic Market Size by Country
8.1.1 Latin America Dendritic Cell Therapy Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dendritic Cell Therapy Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Dendritic Cell Therapy Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Dendritic Cell Therapy Vaccine Forecasted Market Size by Country
8.2.1 Latin America Dendritic Cell Therapy Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dendritic Cell Therapy Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Dendritic Cell Therapy Vaccine by Country
9.1 Middle East and Africa Dendritic Cell Therapy Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Dendritic Cell Therapy Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dendritic Cell Therapy Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Dendritic Cell Therapy Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Dendritic Cell Therapy Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Dendritic Cell Therapy Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dendritic Cell Therapy Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Argos Therapeutics
10.1.1 Argos Therapeutics Company Information
10.1.2 Argos Therapeutics Introduction and Business Overview
10.1.3 Argos Therapeutics Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Argos Therapeutics Dendritic Cell Therapy Vaccine Products Offered
10.1.5 Argos Therapeutics Recent Development
10.2 JW Creagene
10.2.1 JW Creagene Company Information
10.2.2 JW Creagene Introduction and Business Overview
10.2.3 JW Creagene Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 JW Creagene Dendritic Cell Therapy Vaccine Products Offered
10.2.5 JW Creagene Recent Development
10.3 DanDrit Biotech
10.3.1 DanDrit Biotech Company Information
10.3.2 DanDrit Biotech Introduction and Business Overview
10.3.3 DanDrit Biotech Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 DanDrit Biotech Dendritic Cell Therapy Vaccine Products Offered
10.3.5 DanDrit Biotech Recent Development
10.4 DCPrime
10.4.1 DCPrime Company Information
10.4.2 DCPrime Introduction and Business Overview
10.4.3 DCPrime Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 DCPrime Dendritic Cell Therapy Vaccine Products Offered
10.4.5 DCPrime Recent Development
10.5 Elios Therapeutics Inc
10.5.1 Elios Therapeutics Inc Company Information
10.5.2 Elios Therapeutics Inc Introduction and Business Overview
10.5.3 Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Products Offered
10.5.5 Elios Therapeutics Inc Recent Development
10.6 ImmunoCellular Therapeutics Ltd
10.6.1 ImmunoCellular Therapeutics Ltd Company Information
10.6.2 ImmunoCellular Therapeutics Ltd Introduction and Business Overview
10.6.3 ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Products Offered
10.6.5 ImmunoCellular Therapeutics Ltd Recent Development
10.7 Immunicum AB
10.7.1 Immunicum AB Company Information
10.7.2 Immunicum AB Introduction and Business Overview
10.7.3 Immunicum AB Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Immunicum AB Dendritic Cell Therapy Vaccine Products Offered
10.7.5 Immunicum AB Recent Development
10.8 Tella Inc
10.8.1 Tella Inc Company Information
10.8.2 Tella Inc Introduction and Business Overview
10.8.3 Tella Inc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Tella Inc Dendritic Cell Therapy Vaccine Products Offered
10.8.5 Tella Inc Recent Development
10.9 Northwest Biotherapeutics Inc
10.9.1 Northwest Biotherapeutics Inc Company Information
10.9.2 Northwest Biotherapeutics Inc Introduction and Business Overview
10.9.3 Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Products Offered
10.9.5 Northwest Biotherapeutics Inc Recent Development
10.10 Glaxo plc
10.10.1 Glaxo plc Company Information
10.10.2 Glaxo plc Introduction and Business Overview
10.10.3 Glaxo plc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Glaxo plc Dendritic Cell Therapy Vaccine Products Offered
10.10.5 Glaxo plc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dendritic Cell Therapy Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dendritic Cell Therapy Vaccine Industrial Chain Analysis
11.4 Dendritic Cell Therapy Vaccine Market Dynamics
11.4.1 Dendritic Cell Therapy Vaccine Industry Trends
11.4.2 Dendritic Cell Therapy Vaccine Market Drivers
11.4.3 Dendritic Cell Therapy Vaccine Market Challenges
11.4.4 Dendritic Cell Therapy Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dendritic Cell Therapy Vaccine Distributors
12.3 Dendritic Cell Therapy Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Intravenous Injection
Table 2. Major Company of Subcutaneous Injection
Table 3. Major Company of Intratumoral Injection
Table 4. Global Dendritic Cell Therapy Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (K Units)
Table 6. Global Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (US& Million)
Table 8. Global Dendritic Cell Therapy Vaccine Market Share in Value by Type (2018-2024)
Table 9. Global Dendritic Cell Therapy Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Dendritic Cell Therapy Vaccine Sales by Type (2024-2029) & (K Units)
Table 11. Global Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Dendritic Cell Therapy Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Dendritic Cell Therapy Vaccine Sales Market Share in Value by Type (2024-2029)
Table 14. Global Dendritic Cell Therapy Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (K Units)
Table 16. North America Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Dendritic Cell Therapy Vaccine Sales (K Units) by Type (2018-2024)
Table 18. Europe Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Dendritic Cell Therapy Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Dendritic Cell Therapy Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Latin America Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Dendritic Cell Therapy Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Dendritic Cell Therapy Vaccine Sales by Company (2018-2024) & (K Units)
Table 26. Global Dendritic Cell Therapy Vaccine Sales Share by Company (2018-2024)
Table 27. Global Dendritic Cell Therapy Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Dendritic Cell Therapy Vaccine Revenue Share by Company (2018-2024)
Table 29. Global Market Dendritic Cell Therapy Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Dendritic Cell Therapy Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Dendritic Cell Therapy Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dendritic Cell Therapy Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into Dendritic Cell Therapy Vaccine Market
Table 34. Key Manufacturers Dendritic Cell Therapy Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Dendritic Cell Therapy Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Dendritic Cell Therapy Vaccine Sales by Region (2018-2024) & (K Units)
Table 38. Global Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Dendritic Cell Therapy Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Dendritic Cell Therapy Vaccine Sales Market Share in Value by Region (2018-2024)
Table 41. Global Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Dendritic Cell Therapy Vaccine Sales by Region (2024-2029) & (K Units)
Table 43. Global Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Dendritic Cell Therapy Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Dendritic Cell Therapy Vaccine Sales Market Share in Value by Region (2024-2029)
Table 46. Global Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Dendritic Cell Therapy Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) & (K Units)
Table 49. Global Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Dendritic Cell Therapy Vaccine Sales Market Share in Value by Application (2018-2024)
Table 52. Global Dendritic Cell Therapy Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Dendritic Cell Therapy Vaccine Sales by Application (2024-2029) & (K Units)
Table 54. Global Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Dendritic Cell Therapy Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Dendritic Cell Therapy Vaccine Sales Market Share in Value by Application (2024-2029)
Table 57. Global Dendritic Cell Therapy Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) (K Units)
Table 59. North America Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) (K Units)
Table 61. Europe Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Latin America Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 69. North America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2018-2024)
Table 72. North America Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. North America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 77. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 81. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Dendritic Cell Therapy Vaccine Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Dendritic Cell Therapy Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Dendritic Cell Therapy Vaccine Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Dendritic Cell Therapy Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Dendritic Cell Therapy Vaccine Sales Market Share in Value by Country (2024-2029)
Table 108. Argos Therapeutics Company Information
Table 109. Argos Therapeutics Introduction and Business Overview
Table 110. Argos Therapeutics Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Argos Therapeutics Dendritic Cell Therapy Vaccine Product
Table 112. Argos Therapeutics Recent Development
Table 113. JW Creagene Company Information
Table 114. JW Creagene Introduction and Business Overview
Table 115. JW Creagene Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. JW Creagene Dendritic Cell Therapy Vaccine Product
Table 117. JW Creagene Recent Development
Table 118. DanDrit Biotech Company Information
Table 119. DanDrit Biotech Introduction and Business Overview
Table 120. DanDrit Biotech Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. DanDrit Biotech Dendritic Cell Therapy Vaccine Product
Table 122. DanDrit Biotech Recent Development
Table 123. DCPrime Company Information
Table 124. DCPrime Introduction and Business Overview
Table 125. DCPrime Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. DCPrime Dendritic Cell Therapy Vaccine Product
Table 127. DCPrime Recent Development
Table 128. Elios Therapeutics Inc Company Information
Table 129. Elios Therapeutics Inc Introduction and Business Overview
Table 130. Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Product
Table 132. Elios Therapeutics Inc Recent Development
Table 133. ImmunoCellular Therapeutics Ltd Company Information
Table 134. ImmunoCellular Therapeutics Ltd Introduction and Business Overview
Table 135. ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Product
Table 137. ImmunoCellular Therapeutics Ltd Recent Development
Table 138. Immunicum AB Company Information
Table 139. Immunicum AB Introduction and Business Overview
Table 140. Immunicum AB Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Immunicum AB Dendritic Cell Therapy Vaccine Product
Table 142. Immunicum AB Recent Development
Table 143. Tella Inc Company Information
Table 144. Tella Inc Introduction and Business Overview
Table 145. Tella Inc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Tella Inc Dendritic Cell Therapy Vaccine Product
Table 147. Tella Inc Recent Development
Table 148. Northwest Biotherapeutics Inc Company Information
Table 149. Northwest Biotherapeutics Inc Introduction and Business Overview
Table 150. Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Product
Table 152. Northwest Biotherapeutics Inc Recent Development
Table 153. Glaxo plc Company Information
Table 154. Glaxo plc Introduction and Business Overview
Table 155. Glaxo plc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Glaxo plc Dendritic Cell Therapy Vaccine Product
Table 157. Glaxo plc Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Dendritic Cell Therapy Vaccine Market Trends
Table 161. Dendritic Cell Therapy Vaccine Market Drivers
Table 162. Dendritic Cell Therapy Vaccine Market Challenges
Table 163. Dendritic Cell Therapy Vaccine Market Restraints
Table 164. Dendritic Cell Therapy Vaccine Distributors List
Table 165. Dendritic Cell Therapy Vaccine Downstream Customers
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Dendritic Cell Therapy Vaccine Product Picture
Figure 2. Global Dendritic Cell Therapy Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Dendritic Cell Therapy Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Dendritic Cell Therapy Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Intravenous Injection
Figure 6. Global Intravenous Injection Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Subcutaneous Injection
Figure 8. Global Subcutaneous Injection Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Intratumoral Injection
Figure 10. Global Intratumoral Injection Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Dendritic Cell Therapy Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Dendritic Cell Therapy Vaccine Sales Market Share by Type in 2022 & 2029
Figure 13. North America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Dendritic Cell Therapy Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Dendritic Cell Therapy Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dendritic Cell Therapy Vaccine Revenue in 2022
Figure 25. Dendritic Cell Therapy Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Lung Cancer
Figure 27. Global Lung Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Prostatic Cancer
Figure 29. Global Prostatic Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Dendritic Cell Therapy Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Dendritic Cell Therapy Vaccine Sales Market Share by Application in 2022 & 2029
Figure 34. North America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Dendritic Cell Therapy Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Dendritic Cell Therapy Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Dendritic Cell Therapy Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Dendritic Cell Therapy Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Dendritic Cell Therapy Vaccine Manufacturing Cost Structure
Figure 45. Dendritic Cell Therapy Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries